A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

Roche logo

Roche

Status

Completed

Conditions

Breast Cancer

Treatments

Other: eBC treated participants

Study type

Observational

Funder types

Industry

Identifiers

NCT02761616
ML30038

Details and patient eligibility

About

This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.

Enrollment

76 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Participants with histologically confirmed breast cancer treated for early breast cancer (eBC) with first metastatic relapse disease in the period from January 1, 2014 and December 31, 2015

Exclusion criteria

Not Applicable

Trial design

76 participants in 1 patient group

eBC treated participants
Description:
Participants with metastatic disease after previously being treated for eBC were observed for 24 months.
Treatment:
Other: eBC treated participants

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems